Insider Trading History of Cohen Kenneth M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Cohen Kenneth M since 2006. The trader's CIK number is 1346981. At the time of the last reporting, Cohen Kenneth M was the President and CEO of Mabvax Therapeutics Holdings, Inc.. (stock ticker symbol MBVX). Also see all insider trading activities at Mabvax Therapeutics Holdings, Inc..

Note that in the past Cohen Kenneth M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Mabvax Therapeutics Holdings, Inc. (MBVX) by Cohen Kenneth M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 MBVX 0 $0 35,440 $30,292 100,513 $0
2017 MBVX 0 $0 0 $0 1,543 $0
2016 MBVX 3,119 $0 0 $0 11,417 $0
2015 MBVX 3,500 $8,049 0 $0 0 $0
2014 MBVX 6,500 $14,140 0 $0 0 $0

Yearly summary of insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) by Cohen Kenneth M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 SOMX 0 $0 43,795 $617,661 15,000 $18,000
2006 SOMX 0 $0 31,205 $434,614 0 $0


Insider trading activities at 2 companies by Cohen Kenneth M:

1. Mabvax Therapeutics Holdings, Inc. (MBVX)

2. Somaxon Pharmaceuticals, Inc. (SOMX)

Table 1. Insider trading of Mabvax Therapeutics Holdings, Inc. (MBVX) by Cohen Kenneth M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-04-02 MBVX Option Ex 513 .00 0
2018-01-23 MBVX Sale 17,444 .87 15,176
2018-01-24 MBVX Sale 17,996 .84 15,116
2018-01-08 MBVX Option Ex 100,000 .00 0
2017-04-02 MBVX Option Ex 1,543 .00 0
2016-08-17 MBVX Buy 3,119 .00 0
2016-04-04 MBVX Option Ex 11,417 .00 0
2015-05-22 MBVX Buy 3,500 2.30 8,049
2014-12-17 MBVX Buy 2,500 1.80 4,500
2014-12-16 MBVX Buy 4,000 2.41 9,640

Table 2. Insider trading of Somaxon Pharmaceuticals, Inc. (SOMX) by Cohen Kenneth M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-05-11 SOMX Option Ex 15,000 1.20 18,000
2007-04-25 SOMX Sale 23,795 15.14 360,161
2007-04-05 SOMX Sale 200 12.50 2,500
2007-04-09 SOMX Sale 4,800 12.55 60,220
2007-03-14 SOMX Sale 5,000 12.53 62,625
2007-02-15 SOMX Sale 5,000 12.96 64,790
2007-01-03 SOMX Sale 5,000 13.47 67,365
2006-12-18 SOMX Sale 1,502 15.03 22,576
2006-12-19 SOMX Sale 4,713 15.00 70,699
2006-12-20 SOMX Sale 3,315 15.00 49,738
2006-12-01 SOMX Sale 5,000 13.10 65,519
2006-11-13 SOMX Sale 398 15.11 6,013
2006-11-14 SOMX Sale 1,045 15.03 15,709
2006-11-15 SOMX Sale 64 15.02 961
2006-11-07 SOMX Sale 50 15.00 750
2006-11-01 SOMX Sale 5,000 14.45 72,265
2006-10-23 SOMX Sale 118 15.03 1,772
2006-10-05 SOMX Sale 1,219 12.57 15,320
2006-10-06 SOMX Sale 3,172 13.15 41,714
2006-10-02 SOMX Sale 525 12.62 6,626
2006-10-04 SOMX Sale 84 12.50 1,050
2006-09-25 SOMX Sale 3,689 12.84 47,355
2006-09-26 SOMX Sale 1,311 12.62 16,547

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cohen Kenneth M (President and CEO of Mabvax Therapeutics Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.